Revisions of 'Follicular lymphoma (NHL)'
-
Revision 7 - created about 1 year ago by Tee Yu Jin - view changesetDate: 2023-03-23 03:29:01 UTC Disclosures:
At the time the revision was created Tee Yu Jin had no financial relationships to ineligible companies to disclose.
View Tee Yu Jin's current disclosures Reviewed by: Joshua Yap -
Revision 6 - created about 1 year ago by James Sheldon - view changesetDate: 2023-03-21 21:46:18 UTC Disclosures:
At the time the revision was created James Sheldon had no financial relationships to ineligible companies to disclose.
View James Sheldon's current disclosures Reviewed by: Tee Yu Jin -
Revision 5 - created about 1 year ago by James Sheldon - view changesetDate: 2023-03-15 00:35:46 UTC Disclosures:
At the time the revision was created James Sheldon had no financial relationships to ineligible companies to disclose.
View James Sheldon's current disclosures Reviewed by: Joachim Feger -
Revision 4 - created about 1 year ago by James Sheldon - view changesetDate: 2023-03-14 22:55:52 UTC Disclosures:
At the time the revision was created James Sheldon had no financial relationships to ineligible companies to disclose.
View James Sheldon's current disclosures Reviewed by: Frank Gaillard -
Revision 3 - created about 1 year ago by James Sheldon - view changesetDate: 2023-03-06 10:31:36 UTC Disclosures:
At the time the revision was created James Sheldon had no financial relationships to ineligible companies to disclose.
View James Sheldon's current disclosures Reviewed by: Joachim Feger -
Revision 2 - created about 1 year ago by James Sheldon - view changesetDate: 2023-02-28 21:37:20 UTC Disclosures:
At the time the revision was created James Sheldon had no financial relationships to ineligible companies to disclose.
View James Sheldon's current disclosures Reviewed by: Ayla Al Kabbani -
Revision 1 - created about 1 year ago by James Sheldon - view changesetDate: 2023-02-23 22:29:15 UTC Disclosures:
At the time the revision was created James Sheldon had no financial relationships to ineligible companies to disclose.
View James Sheldon's current disclosures Reviewed by: Joachim Feger
Unfortunately some older revisions may not be able to be viewed or restored.
Radiopaedia.org is a collaborative effort and anyone can contribute. Every revision counts. Learn more about contributing.
Each article also undergoes a sophisticated editorial process to ensure the high quality of Radiopaedia.org. Through open contributions by many different medical professionals, editorial oversight from our excellent editorial and expert review boards, and continual moderation, we can continue to provide the best, free radiology resource online.